FLAG
NYSEFirst Light Acquisition Group Inc.
This company no longer trades as FLAG. The ticker now belongs to a fund, Global X Funds Global X S&P 500 U.S. Market Leaders Top 50 ETF.
First Light Acquisition Group Inc. (FLAG) is a Biotechnology: Biological Products (No Diagnostic Substances) company listed on NYSE. There were no new wire items for FLAG in the last 30 days. The most recent was published Feb 14, 2024.
Latest news
25 items- 13D/GSEC Form SC 13G/A filed by First Light Acquisition Group Inc. (Amendment)SC 13G/A - Calidi Biotherapeutics, Inc. (0001855485) (Subject)
- 13D/GSEC Form SC 13G/A filed by First Light Acquisition Group Inc. (Amendment)SC 13G/A - Calidi Biotherapeutics, Inc. (0001855485) (Subject)
- 13D/GSEC Form SC 13G/A filed by First Light Acquisition Group Inc. (Amendment)SC 13G/A - Calidi Biotherapeutics, Inc. (0001855485) (Subject)
- 13D/GSEC Form SC 13G/A filed by First Light Acquisition Group Inc. (Amendment)SC 13G/A - Calidi Biotherapeutics, Inc. (0001855485) (Subject)
- SECFirst Light Acquisition Group Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits8-K - Calidi Biotherapeutics, Inc. (0001855485) (Filer)
- SECSEC Form 424B3 filed by First Light Acquisition Group Inc.424B3 - Calidi Biotherapeutics, Inc. (0001855485) (Filer)
- 13D/GSEC Form SC 13G/A filed by First Light Acquisition Group Inc. (Amendment)SC 13G/A - Calidi Biotherapeutics, Inc. (0001855485) (Subject)
- 13D/GSEC Form SC 13G/A filed by First Light Acquisition Group Inc. (Amendment)SC 13G/A - Calidi Biotherapeutics, Inc. (0001855485) (Subject)
- SECFirst Light Acquisition Group Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure8-K - Calidi Biotherapeutics, Inc. (0001855485) (Filer)
- SECSEC Form S-1/A filed by First Light Acquisition Group Inc. (Amendment)S-1/A - Calidi Biotherapeutics, Inc. (0001855485) (Filer)
- SECSEC Form 424B3 filed by First Light Acquisition Group Inc.424B3 - Calidi Biotherapeutics, Inc. (0001855485) (Filer)
- SECFirst Light Acquisition Group Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Financial Statements and Exhibits8-K - Calidi Biotherapeutics, Inc. (0001855485) (Filer)
- SECSEC Form S-1 filed by First Light Acquisition Group Inc.S-1 - Calidi Biotherapeutics, Inc. (0001855485) (Filer)
- SECSEC Form 424B3 filed by First Light Acquisition Group Inc.424B3 - Calidi Biotherapeutics, Inc. (0001855485) (Filer)
- SECSEC Form EFFECT filed by First Light Acquisition Group Inc.EFFECT - Calidi Biotherapeutics, Inc. (0001855485) (Filer)
- SECSEC Form S-1/A filed by First Light Acquisition Group Inc. (Amendment)S-1/A - Calidi Biotherapeutics, Inc. (0001855485) (Filer)
- SECFirst Light Acquisition Group Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - Calidi Biotherapeutics, Inc. (0001855485) (Filer)
- SECSEC Form S-1/A filed by First Light Acquisition Group Inc. (Amendment)S-1/A - Calidi Biotherapeutics, Inc. (0001855485) (Filer)
- SECFirst Light Acquisition Group Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - Calidi Biotherapeutics, Inc. (0001855485) (Filer)
- INSIDERZulueta Alfonso G was granted 5,644 shares, increasing direct ownership by 4% to 133,301 units (SEC Form 4)4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
- INSIDERStewart Alan R. was granted 7,282 shares, increasing direct ownership by 15% to 54,655 units (SEC Form 4)4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
- INSIDERSchoeneck James A was granted 10,625 shares, increasing direct ownership by 62% to 27,872 units (SEC Form 4)4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
- INSIDERLeftwich Scott was granted 8,958 shares, increasing direct ownership by 2% to 469,903 units (SEC Form 4)4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
- INSIDERSEC Form 4 filed by Camaisa Allan4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
- INSIDERVecchiolla Thomas A. was granted 7,709 shares, increasing direct ownership by 2% to 365,105 units (SEC Form 4)4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
FLAG FAQ
7 questionsWhat does First Light Acquisition Group Inc. do?
First Light Acquisition Group, Inc. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2021 and is headquartered in Reston, Virginia.What is the latest news on FLAG?
Quantisnow has not tracked any new filings, ratings or press releases for FLAG in the last 30 days. The most recent wire item was published on February 14, 2024.Where does FLAG stock trade?
First Light Acquisition Group Inc. (FLAG) is listed on NYSE.What sector and industry is FLAG in?
First Light Acquisition Group Inc. operates in the Health Care sector, Biotechnology: Biological Products (No Diagnostic Substances) industry.When did First Light Acquisition Group Inc. go public?
First Light Acquisition Group Inc. (FLAG) completed its IPO in 2021.What companies are similar to FLAG?
Notable peers in the same industry include AMGN (Amgen Inc.), GILD (Gilead Sciences Inc.), MRNA (Moderna Inc.), ARGX (argenx SE), RVMD (Revolution Medicines Inc.). Compare FLAG side-by-side with any of them on Quantisnow.How can I track FLAG on Quantisnow?
Quantisnow aggregates First Light Acquisition Group Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow FLAG to receive live email and push alerts on every new disclosure.